Rate My Professor Lynley Lewis

Dr. Lynley Lewis is a Senior Research Fellow in the Translational Biodiscovery Laboratory at the Christchurch Heart Institute, Department of Medicine, University of Otago, Christchurch, within the Faculty of Medicine. Her research centers on developing and validating novel biomarker assays essential for diagnosing and prognosticating cardiovascular conditions in both clinical and preclinical contexts. The laboratory's expertise encompasses assays for key hormones such as atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), N-terminal proBNP (NT-proBNP), C-type natriuretic peptide (CNP), adrenomedullin, angiotensin II, angiotensin converting enzyme activity, plasma renin activity, arginine vasopressin, adrenocorticotropic hormone (ACTH), cortisol, aldosterone, endothelin, cyclic GMP (cGMP), cyclic AMP (cAMP), catecholamines, ghrelin peptides, and signal peptide fragments. Utilizing technologies including radioimmunoassay (RIA), enzyme-linked immunosorbent assay (ELISA), Luminex, Roche Cobas, and Brahms Kryptor, the team conducts in vitro and ex vivo testing, cell culture, and isolated heart studies under FDA-level audits and ISO15189 accreditation. The laboratory also performs commercial studies for pharmaceutical companies such as Roche, Abbott, Sphingotec, and ThermoFisher.